Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis

Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis

The 2016 WHO classification recognized pre-fibrotic primary myelofibrosis (pre-PMF) as a distinct entity. Nevertheless, a prognostic model specific for pre-PMF is still lacking. Our aim was to identify the most relevant clinical, histological, and driver mutation information at diagnosis to evaluate...

Full description

Bibliographic Details
Main Authors: Daniele Cattaneo, Claudia Vener, Elena Maria Elli, Cristina Bucelli, Nicole Galli, Fabrizio Cavalca, Giuseppe Auteri, Donatella Vincelli, Bruno Martino, Umberto Gianelli, Francesca Palandri, Alessandra Iurlo
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
primary myelofibrosis
pre-fibrotic
prognosis
scoring system
IPSS
DIPSS
Online Access:https://www.mdpi.com/2072-6694/14/7/1799

Internet

https://www.mdpi.com/2072-6694/14/7/1799

Similar Items